High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

BMC Infectious Diseases
Todisoa AndriatahinaVincent Richard

Abstract

Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae have spread worldwide but there are few reports on carriage in hospitals in low-income countries. ESBL-producing Enterobacteriaceae (ESBL-PE) have been increasingly isolated from nosocomial infections in Antananarivo, Madagascar. we conducted a prevalence survey in a pediatric unit from March to April 2008 Patient rectal swabs were sampled on the first and the last day of hospitalization. Medical staff and environment were also sampled. Rectal and environmental swabs were immediately plated onto Drigalski agar supplemented with 3 mg/liter of ceftriaxon. Fecal carriage was detected in 21.2% of 244 infants on admission and 57.1% of 154 on discharge, after more than 48 hours of hospitalization (p < 0.001). The species most frequently detected on admission were Escherichia coli and Klebsiella pneumoniae (36.9%), whereas, on discharge, K. pneumoniae was the species most frequently detected (52.7%). ESBL-associated resistances were related to trimethoprim-sulfamethoxazole (91.3%), gentamicin (76.1%), ciprofloxacin (50.0%), but not to amikacin and imipenem. The increased prevalence of carriage during hospitalization was related to standard antimicrobial therapy. The ...Continue Reading

References

Oct 1, 1975·Antimicrobial Agents and Chemotherapy·H Ogawara
Oct 1, 1995·Clinical Microbiology Reviews·D M Livermore
Feb 18, 1999·JAMA : the Journal of the American Medical Association·J WienerR A Weinstein
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L Paterson, V L Yu
May 19, 2000·Antimicrobial Agents and Chemotherapy·M OsterbladP Kotilainen
Apr 13, 2001·Journal of the American Geriatrics Society·W E TrickW R Jarvis
Aug 29, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B R Levin
Feb 15, 2002·Journal of the American Geriatrics Society·M Westerman, R G Bennett
Apr 25, 2002·Emerging Infectious Diseases·Marc Lipsitch, Matthew H Samore
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Laura BriñasCarmen Torres
Nov 21, 2002·The Pediatric Infectious Disease Journal·Nalini SinghJoseph M Campos
Jul 16, 2003·Current Opinion in Infectious Diseases·Rafael CantónFernando Baquero
Sep 16, 2003·Emerging Infectious Diseases·Beatriz MirelisGuillem Prats
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·David L SmithSimon A Levin
Mar 5, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anthony D HarrisEli N Perencevich
Dec 2, 2006·The Journal of Antimicrobial Chemotherapy·Frédérique RandrianirinaAntoine Talarmin
Dec 21, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F J Castillo GarcíaC Pitart Ferré
Oct 13, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Abdulrahman Abdulla KaderKatapadi Ananthkrishna Kamath
Feb 23, 2008·The Lancet Infectious Diseases·Johann D D Pitout, Kevin B Laupland
Jun 19, 2008·Journal of Paediatrics and Child Health·Serap DemirAysegul Yagci
Mar 10, 2010·Journal of Infection in Developing Countries·Frédérique RandrianirinaVincent Richard
Mar 29, 2014·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Christoph LübbertUdo X Kaisers

❮ Previous
Next ❯

Citations

Aug 14, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C M LonchelP De Mol
Mar 16, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A Boutet-DuboisJ-P Lavigne
Feb 27, 2014·BMC Infectious Diseases·Frederique RandrianirinaAntoine Talarmin
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul-Louis WoertherAntoine Andremont
Dec 30, 2014·Journal of Global Infectious Diseases·Rumpa SahaAnkita Kumari
Jan 7, 2014·American Journal of Infection Control·Mouna TarchounaJalel Boukadida
Nov 12, 2013·The Journal of Hospital Infection·C RotheS Thompson
May 8, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C Lonchel MagouéP De Mol
Mar 7, 2017·Shokuhin eiseigaku zasshi. Journal of the Food Hygienic Society of Japan·Shiori YamamotoShizunobu Igimi
Jan 18, 2017·Antimicrobial Resistance and Infection Control·Marcelyn T MagwenziAlexander M Aiken
Oct 5, 2013·Clinical Microbiology Reviews·Paul-Louis WoertherAntoine Andremont
Mar 5, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ngure KagiaSusan C Morpeth
Apr 18, 2020·The Journal of Antimicrobial Chemotherapy·Andriniaina RakotondrasoaJean-Marc Collard
Jun 7, 2019·International Journal of Environmental Research and Public Health·Claudia PetersAnja Schablon
Jan 25, 2017·The Journal of Antimicrobial Chemotherapy·Michael PadgetUNKNOWN BIRDY Study Group
Dec 12, 2018·The Pediatric Infectious Disease Journal·Zoly Nantenaina RanosiarisoaPatrick Imbert
Aug 25, 2011·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Saori YasunagaNaohiro Shibata
Jul 22, 2017·Frontiers in Public Health·Noellie GayEric Cardinale
Aug 19, 2021·Infection & chemotherapy·Bich Thuy DuongMary Louise McLaws

❮ Previous
Next ❯

Software Mentioned

Statistica

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.